Correlation Between Biostage and Regenicin
Can any of the company-specific risk be diversified away by investing in both Biostage and Regenicin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biostage and Regenicin into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biostage and Regenicin, you can compare the effects of market volatilities on Biostage and Regenicin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biostage with a short position of Regenicin. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biostage and Regenicin.
Diversification Opportunities for Biostage and Regenicin
Pay attention - limited upside
The 3 months correlation between Biostage and Regenicin is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Biostage and Regenicin in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regenicin and Biostage is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biostage are associated (or correlated) with Regenicin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regenicin has no effect on the direction of Biostage i.e., Biostage and Regenicin go up and down completely randomly.
Pair Corralation between Biostage and Regenicin
If you would invest 0.01 in Regenicin on September 15, 2024 and sell it today you would earn a total of 0.00 from holding Regenicin or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 1.56% |
Values | Daily Returns |
Biostage vs. Regenicin
Performance |
Timeline |
Biostage |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Regenicin |
Biostage and Regenicin Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Biostage and Regenicin
The main advantage of trading using opposite Biostage and Regenicin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biostage position performs unexpectedly, Regenicin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regenicin will offset losses from the drop in Regenicin's long position.Biostage vs. Biotron Limited | Biostage vs. biOasis Technologies | Biostage vs. Covalon Technologies | Biostage vs. Mosaic Immunoengineering |
Regenicin vs. Denali Therapeutics | Regenicin vs. Cardiff Oncology | Regenicin vs. Cytodyn | Regenicin vs. Inovio Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |